Biocompatible narrow size nanohydrogels for drug delivery

Biodegradable polymers have gained attention for controlled drug delivery due to their potential for sustained release. Herein, a novel series of cross-linked, narrow size nanohydrogels (NHGs) with tunable sizes (20-500 nm), devoid of toxicity, and suitable for diverse biological applications were developed. These NHGs are synthesized via a thermo-responsive self-assembly process followed by confined polymerization. Ester cross-linkers were introduced into the polymeric backbone to enhance biodegradability. The NHGs comprise ideal candidates for drug delivery due to their long circulation in blood after iv administration. The anti-oxidant curcumin and the antifungal drug amphotericin B (AmB) as hydrophobic drug models were successfully loaded. The AmB-loaded NHGs showed improved antifungal activity against clinical isolates of molds and yeasts and markedly reduced morbidity in murine models inoculated with lethal doses of the pathogenic mold Candida albicans as compared to the commercial AmB formulation Fungizone. The NHGs thereby offer a versatile platform for controlled drug release.

Authors

Institutions

Publication Details

Journal
Nanomedicine Nanotechnology Biology and Medicine
Published
2025-04-23
DOI
https://doi.org/10.1016/j.nano.2025.102824
Citations
3
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
1.79
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biocompatible narrow size nanohydrogels for drug delivery

María L. Cuestas, Lakshmanan Eswaran, Gérardo Byk, Yana Shadkchan et al.
3 citations
Nanomedicine Nanotechnology Biology and Medicine
Nanoparticle-Based Drug Delivery
1.79
article

Biocompatible narrow size nanohydrogels for drug delivery

María L. Cuestas, Lakshmanan Eswaran, Gérardo Byk, Yana Shadkchan, Natalie Abudi, Nir Osherov, Gila Kazimirsky, Rinat Abramovitch, Shaul D. Cemal
article en
3 citations

Abstract

Biodegradable polymers have gained attention for controlled drug delivery due to their potential for sustained release. Herein, a novel series of cross-linked, narrow size nanohydrogels (NHGs) with tunable sizes (20-500 nm), devoid of toxicity, and suitable for diverse biological applications were developed. These NHGs are synthesized via a thermo-responsive self-assembly process followed by confined polymerization. Ester cross-linkers were introduced into the polymeric backbone to enhance biodegradability. The NHGs comprise ideal candidates for drug delivery due to their long circulation in blood after iv administration. The anti-oxidant curcumin and the antifungal drug amphotericin B (AmB) as hydrophobic drug models were successfully loaded. The AmB-loaded NHGs showed improved antifungal activity against clinical isolates of molds and yeasts and markedly reduced morbidity in murine models inoculated with lethal doses of the pathogenic mold Candida albicans as compared to the commercial AmB formulation Fungizone. The NHGs thereby offer a versatile platform for controlled drug release.

Nanomedicine Nanotechnology Biology and MedicineVol. 66
Bar-Ilan University (IL), Consejo Nacional de Investigaciones Científicas y Técnicas (AR), Tel Aviv University (IL), Universidad de Buenos Aires (AR), Hadassah Medical Center (IL)
Openalex Percentile: Top 17%
Nanoparticle-Based Drug Delivery
1.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Biocompatible narrow size nanohydrogels for drug delivery — María L. Cuestas, Lakshmanan Eswaran, et al. · Nanomedicine Nanotechnology Biology and Medicine (2025) | TGRS Research Map | TGRS